Skip to main content
. 2023 Mar 30;17(3):e0011236. doi: 10.1371/journal.pntd.0011236

Fig 2. Number and percentage of participants experiencing solicited injection site events after any dose of vaccine by event, maximum severity, and vaccine group.

Fig 2